Myeloid lineage–restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome
No NLRP3 genetic variants were found in any of the analyzed cell types derived from 2 patients with Schnitzler syndrome without NLRP3 variants in whole blood (Table I). Because we have previously demonstrated that IL-1β is a pivotal mediator of the clinical signs of Schnitzler syndrome,2,5 we proce...
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 135; no. 2; pp. 561 - 564.e4 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.02.2015
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0091-6749 1097-6825 1097-6825 |
DOI | 10.1016/j.jaci.2014.07.050 |
Cover
Summary: | No NLRP3 genetic variants were found in any of the analyzed cell types derived from 2 patients with Schnitzler syndrome without NLRP3 variants in whole blood (Table I). Because we have previously demonstrated that IL-1β is a pivotal mediator of the clinical signs of Schnitzler syndrome,2,5 we proceeded to investigate the functional consequences of the NLRP3 mosaic mutations on IL-1β and IL-6 production in PBMCs (see the Methods section in this article's Online Repository at www.jacionline.org). The identified variant is considered a benign polymorphism.E5 In patient 7 we detected a known missense mutation in the NACHT domain of the NLRP3 gene (c.1569C>G; p.F523L), which was previously reported as disease causing in 2 infants with NOMID/CINCA, a severe early-onset form of CAPS.E6Canonical SS, Variants located in a canonical splice site; Coding+SS, all variants located either in exonic regions or canonical splice sites; Indels, Insertions or deletions; Known variant (HGMD), variants described as pathogenic in the Human Gene Mutation Database (www.hgmd.org); Missense (phyloP >2.5),E4 highly conserved missense variants with a phyloP >2.5; Nonsense, nonsense variants; Nonsynonymous, variants leading to an amino acid change; Not seen before (in house), variants that have not been detected in 672 in-house sequenced whole exomes; Patient, patient who has undergone whole-exome sequencing; Total no. of variants, all variants detected by using whole-exome sequencing. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 14 ObjectType-Article-2 content type line 23 |
ISSN: | 0091-6749 1097-6825 1097-6825 |
DOI: | 10.1016/j.jaci.2014.07.050 |